Literature DB >> 12793963

Clinical trials in stroke in 2002.

Meheroz H Rabadi1, John Blass.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12793963     DOI: 10.1007/s11883-003-0045-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  6 in total

1.  "Silent" strokes and dementia.

Authors:  John P Blass; Rajiv R Ratan
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

2.  Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits.

Authors:  Raymond D Pratt; C A Perdomo
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

3.  International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.

Authors:  Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors:  James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

6.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.